GlycoMimetics Inc (GLYC)
1.83
+0.11
(+6.40%)
USD |
NASDAQ |
May 03, 16:00
1.835
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Max Drawdown (5Y): 97.87% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 97.87% |
March 31, 2024 | 97.87% |
February 29, 2024 | 97.87% |
January 31, 2024 | 97.87% |
December 31, 2023 | 97.87% |
November 30, 2023 | 97.87% |
October 31, 2023 | 97.87% |
September 30, 2023 | 97.87% |
August 31, 2023 | 97.87% |
July 31, 2023 | 97.87% |
June 30, 2023 | 97.87% |
May 31, 2023 | 97.87% |
April 30, 2023 | 97.87% |
March 31, 2023 | 97.87% |
February 28, 2023 | 97.87% |
January 31, 2023 | 97.87% |
December 31, 2022 | 97.87% |
November 30, 2022 | 97.87% |
October 31, 2022 | 97.87% |
September 30, 2022 | 97.87% |
August 31, 2022 | 97.87% |
July 31, 2022 | 97.87% |
June 30, 2022 | 97.87% |
May 31, 2022 | 97.87% |
April 30, 2022 | 97.17% |
Date | Value |
---|---|
March 31, 2022 | 96.06% |
February 28, 2022 | 95.90% |
January 31, 2022 | 95.78% |
December 31, 2021 | 94.32% |
November 30, 2021 | 93.33% |
October 31, 2021 | 92.90% |
September 30, 2021 | 92.90% |
August 31, 2021 | 92.90% |
July 31, 2021 | 92.78% |
June 30, 2021 | 92.78% |
May 31, 2021 | 92.78% |
April 30, 2021 | 92.78% |
March 31, 2021 | 92.78% |
February 28, 2021 | 92.78% |
January 31, 2021 | 92.78% |
December 31, 2020 | 92.78% |
November 30, 2020 | 92.78% |
October 31, 2020 | 92.78% |
September 30, 2020 | 92.78% |
August 31, 2020 | 92.78% |
July 31, 2020 | 92.78% |
June 30, 2020 | 92.78% |
May 31, 2020 | 92.78% |
April 30, 2020 | 92.78% |
March 31, 2020 | 92.78% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
77.59%
Minimum
May 2019
97.87%
Maximum
Jun 2022
93.88%
Average
93.12%
Median
Max Drawdown (5Y) Benchmarks
Altimmune Inc | 99.85% |
Cellectar Biosciences Inc | 99.70% |
PDS Biotechnology Corp | 99.86% |
Syros Pharmaceuticals Inc | 98.58% |
Precision BioSciences Inc | 98.55% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -59.39 |
Beta (5Y) | 2.295 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 126.5% |
Historical Sharpe Ratio (5Y) | -0.2673 |
Historical Sortino (5Y) | -0.6424 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 38.05% |